The Acute Myeloid Leukemia Channel is supported with funding from BMS (Silver), and through an educational grant from Jazz Pharmaceuticals.
The Chronic Lymphocytic Leukemia Channel is supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver).
The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
EBMT 2016 | Transforming healthcare with Twitter: A physician’s perspective
At the 2016 Annual Meeting of the European Society for Blood and Marrow Transplantation, held in Valencia, Spain, Navneet Majhail, MD, from Cleveland Clinic, Cleveland, OH, discusses Twitter as a way to engage colleagues and stay up-to-date with the latest medical information from journals and organizations, including the EBMT, European Hematology Association (EHA), American Society of Clinical Oncology (ASCO).
